| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | interleukin 3 receptor subunit alpha | ||||
| GTO ID | GTC2199 |
| Trial ID | NCT04109482 |
| Disease | Blastic Plasmacytoid Dendritic Cell Neoplasm |
| Altered gene | CD123 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MB-102 |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Terminated |
| Title | Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN. |
| Year | 2019 |
| Country | United States |
| Company sponsor | Mustang Bio |
| Other ID(s) | MB102-CD123-001 |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||||||
|
|||||||||||||